Marpai (MRAI) Stock Price, News & Analysis

Company Overview

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Key Stats

• Today's Range: $0.99 to $1.15
• 50-Day Range: $0.82 to $1.15
• 52-Week Range: $0.40 to $2.97
• Volume: 8,470 shs
• Average Volume: 23,761 shs
• Market Capitalization: $16.65 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.00
• Consensus Rating: Buy

Marpai Stock Analysis - MarketRank™

Marpai scored higher than 28% of companies evaluated by MarketBeat, and ranked 254th out of 312 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Marpai has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Marpai has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Marpai is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Marpai is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for MRAI.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Marpai does not currently pay a dividend.

Dividend Growth

Marpai does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for MRAI.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 3 news articles for Marpai this week, compared to 0 articles on an average week.

Search Interest

Only 1 people have searched for MRAI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Marpai insiders have not sold or bought any company stock.

Percentage Held by Insiders

61.30% of the stock of Marpai is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

49.75% of the stock of Marpai is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MRAI Stock Analysis - Frequently Asked Questions

How have MRAI shares performed this year?

Marpai's stock was trading at $0.95 at the beginning of 2025. Since then, MRAI shares have increased by 21.1% and is now trading at $1.15.
View the best growth stocks for 2025 here.

How were Marpai's earnings last quarter?

Marpai, Inc. (NASDAQ:MRAI) posted its quarterly earnings data on Thursday, May, 9th. The company reported ($0.46) EPS for the quarter. The business earned $7.39 million during the quarter.

When did Marpai's stock split?

Shares of Marpai reverse split on the morning of Thursday, June 29th 2023. The 1-4 reverse split was announced on Thursday, June 29th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 29th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

When did Marpai IPO?

Marpai (MRAI) raised $25 million in an IPO on Wednesday, October 27th 2021. The company issued 6,300,000 shares at a price of $4.00 per share. ThinkEquity served as the underwriter for the IPO.

How do I buy shares of Marpai?

Shares of MRAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Marpai own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Marpai investors own include NVIDIA (NVDA), Meta Platforms (META), Snowflake (SNOW), iShares Core S&P 500 ETF (IVV), Tesla (TSLA), Airbnb (ABNB) and Allegion (ALLE).

Company Calendar

• Last Earnings: 5/09/2024
• Today: 3/24/2025
• Next Earnings (Estimated): 3/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Miscellaneous health & allied services, not elsewhere classified
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:MRAI
• CIK: 1844392
• Web: www.marpaihealth.com
• Phone: 646-303-3483
• Fax: N/A
• Employees: 150
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $6.00
• High Stock Price Target: $6.00
• Low Stock Price Target: $6.00
• Potential Upside/Downside: +421.7%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($2.64)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-28,750,000.00
• Net Margins: -85.70%
• Pretax Margin: -86.66%
• Return on Equity: N/A
• Return on Assets: -100.23%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.82
• Quick Ratio: 0.82

Sales & Book Value

• Annual Sales: $34.87 million
• Price / Sales: 0.48
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.72) per share
• Price / Book: -0.67

Miscellaneous

• Outstanding Shares: 14,482,000
• Free Float: 5,605,000
• Market Cap: $16.65 million
• Optionable: No Data
• Beta: 5.02